SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer: Toxicity and quality of life assessment

BACKGROUND: Quality of life (QoL) is one of the most significant issues in prostate cancer treatment decisions. This study aimed to investigate the toxicity of hypofractionated stereotactic radiotherapy (SBRT) and QoL after treatment in localized prostate cancer patients. MATERIALS AND METHODS: A pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rucinska, Monika, Kieszkowska-Grudny, Anna, Nawrocki, Sergiusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919372/
https://www.ncbi.nlm.nih.gov/pubmed/27221312
http://dx.doi.org/10.1007/s00066-016-0971-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919372/
https://www.ncbi.nlm.nih.gov/pubmed/27221312
http://dx.doi.org/10.1007/s00066-016-0971-2

Ejemplares similares